{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:31:13Z","timestamp":1791484273693,"version":"4.3.4"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/nrendo.2015.130","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T08:30:55Z","timestamp":1439886655000},"page":"606-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["Preventing and treating foot complications associated with diabetes mellitus"],"prefix":"10.1038","volume":"11","author":[{"given":"Frank L.","family":"Bowling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Tawqeer","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J. M.","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,18]]},"reference":[{"key":"BFnrendo2015130_CR1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.mcna.2013.03.007","volume":"97","author":"AJ Boulton","year":"2013","unstructured":"Boulton, A. J. The pathway to foot ulceration in diabetes. Med. Clin. North Am. 97, 775\u2013790 (2013).","journal-title":"Med. Clin. North Am."},{"key":"BFnrendo2015130_CR2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"N Singh","year":"2005","unstructured":"Singh, N., Armstrong, D. G. & Lipsky, B. A. Preventing foot ulcers in patients with diabetes. JAMA 293, 217\u2013228 (2005).","journal-title":"JAMA"},{"key":"BFnrendo2015130_CR3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/dme.12545","volume":"31","author":"M Kerr","year":"2014","unstructured":"Kerr, M., Rayman, G. & Jeffcoate, W. J. Cost of diabetic foot disease to the National Health Service in England. Diabetic Med. 31, 1498\u20131504 (2014).","journal-title":"Diabetic Med."},{"key":"BFnrendo2015130_CR4","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2337\/dc12-2285","volume":"36","author":"DG Armstrong","year":"2013","unstructured":"Armstrong, D. G. et al. Mind the gap: disparity between research funding and costs of care for diabetic foot ulcers. Diabetes Care 36, 1815\u20131817 (2013).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1742-481X.2007.00392.x","volume":"4","author":"DG Armstrong","year":"2007","unstructured":"Armstrong, D. G., Wrobel, J. & Robbins, J. M. Are diabetes-related wounds worse than cancer? Int. Wound J. 4, 286\u2013287 (2007).","journal-title":"Int. Wound J."},{"key":"BFnrendo2015130_CR6","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc10-1213","volume":"33","author":"LA Lavery","year":"2010","unstructured":"Lavery, L. A., Hunt, N. A., Ndip, A., Lavery, D. C. & Boulton, A. J. Impact of chronic kidney disease on survival after amputation in individuals with diabetes. Diabetes Care 33, 2365\u20132369 (2010).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR7","first-page":"114","volume":"115","author":"JB Buse","year":"2007","unstructured":"Buse, J. B. et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American heart association and the American diabetes association. Diabetes Care 115, 114\u2013126 (2007).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR8","unstructured":"NICE. Lower limb peripheral arterial disease: diagnosis and management. NICE guidelines [CG147] [online] , (2012)."},{"key":"BFnrendo2015130_CR9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(03)13169-8","volume":"361","author":"WJ Jeffcoate","year":"2003","unstructured":"Jeffcoate, W. J. & Harding, K. Diabetic foot ulcers. Lancet 361, 1545\u20131551 (2003).","journal-title":"Lancet"},{"key":"BFnrendo2015130_CR10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1464-5491.2002.00698.x","volume":"19","author":"CA Abbott","year":"2002","unstructured":"Abbott, C. A. et al. The North West Diabetes Foot Care Study: Incidence of and risk factors for new diabetic foot ulceration in a community-based cohort. Diabetic Med. 19, 377\u2013384 (2002).","journal-title":"Diabetic Med."},{"key":"BFnrendo2015130_CR11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2337\/diacare.25.3.570","volume":"25","author":"IS Muller","year":"2002","unstructured":"Muller, I. S. et al. Foot ulceration and lower limb amputation in type 2 diabetic patients in Dutch primary health care. Diabetes Care 25, 570\u2013574 (2002).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR12","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2337\/diacare.28.8.1869","volume":"28","author":"CA Abbott","year":"2005","unstructured":"Abbott, C. A. et al. Foot ulcer risk is lower in South Asian and African-Caribbean compared to European diabetic patients in the UK: the North-West diabetes foot care study. Diabetes Care 28, 1869\u20131875 (2005).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/dmrr.2319","volume":"28","author":"M Monteiro-Soares","year":"2012","unstructured":"Monteiro-Soares, M. et al. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab. Res. Rev. 28, 574\u2013600 (2012).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnrendo2015130_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1474651411407389","volume":"11","author":"G Leese","year":"2011","unstructured":"Leese, G., Stang, D. & McKnight, J. A national strategic approach to diabetic foot disease in Scotland: a changing culture. Br. J. Diabetes Vasc. Dis. 11, 69\u201373 (2011).","journal-title":"Br. J. Diabetes Vasc. Dis."},{"key":"BFnrendo2015130_CR15","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.1016\/j.mcna.2013.03.008","volume":"97","author":"DJ Margolis","year":"2013","unstructured":"Margolis, D. J. & Jeffcoate, W. J. Epidemiology of foot ulceration and amputation. Med. Clin. N. Amer. 97, 7791\u20137805 (2013).","journal-title":"Med. Clin. N. Amer."},{"key":"BFnrendo2015130_CR16","first-page":"367","volume-title":"Evidence Based Management of Diabetes","author":"AJM Boulton","year":"2012","unstructured":"Boulton, A. J. M. in Evidence Based Management of Diabetes (eds Giten, V. & Busen, J.) 367\u2013382 (TFM Publishing, 2012)."},{"key":"BFnrendo2015130_CR17","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.2337\/dc10-0989","volume":"33","author":"EP Vamos","year":"2010","unstructured":"Vamos, E. P., Bottle, A. & Edmonds, M. E. Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008. Diabetes Care 33, 2592\u20132597 (2010).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR18","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00125-012-2468-6","volume":"55","author":"N Holman","year":"2012","unstructured":"Holman, N., Young, R. J. & Jeffcoate, W. J. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia 55, 1919\u20131925 (2012).","journal-title":"Diabetologia"},{"key":"BFnrendo2015130_CR19","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.2337\/dc12-0511","volume":"35","author":"B Kennon","year":"2012","unstructured":"Kennon, B., Leese, G. P. & Cochrane, L. Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care 35, 2588\u20132590 (2012).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1744-8603-10-6","volume":"10","author":"K Chevreul","year":"2014","unstructured":"Chevreul, K., Berg Brigham, K. & Bouch\u00e9, C. The burden and treatment of diabetes in France. Global Health 10, 6 (2014).","journal-title":"Global Health"},{"key":"BFnrendo2015130_CR21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2337\/dc14-1598","volume":"38","author":"K Pickwell","year":"2015","unstructured":"Pickwell, K. et al. Predictors of lower extremity amputation in patients with an infected diabetic foot ulcer. Diabetes Care 38, 852\u2013857 (2015).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR22","doi-asserted-by":"crossref","first-page":"e11680","DOI":"10.5812\/jjm.11680","volume":"7","author":"A Hadadi","year":"2014","unstructured":"Hadadi, A. et al. Diabetic foot: infections and outcomes in Iranian admitted patients. Jundishapur J. Microbiol. 7, e11680 (2014).","journal-title":"Jundishapur J. Microbiol."},{"key":"BFnrendo2015130_CR23","first-page":"1721","volume":"366","author":"AJM Boulton","year":"2005","unstructured":"Boulton, A. J. M., Vileikyte, L., Ragnarson-Tennvall, G. & Apelqvist, J. The global burden of diabetic foot disease. Lancet 366, 1721\u20131726 (2005).","journal-title":"Lancet"},{"key":"BFnrendo2015130_CR24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L","volume":"15","author":"AJM Boulton","year":"1998","unstructured":"Boulton, A. J. M., Gries, J. A. & Jervell, J. A. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Special Report. Diabetic Med. 15, 508\u2013514 (1998).","journal-title":"Diabetic Med."},{"key":"BFnrendo2015130_CR25","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","volume":"27","author":"AJM Boulton","year":"2004","unstructured":"Boulton, A. J. M., Malik, R. A., Arezzo, J. & Sosenko, J. M. Diabetic somatic neuropathies. Diabetes Care 27, 1458\u20131486 (2004).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","volume":"43","author":"PJ Dyck","year":"1993","unstructured":"Dyck, P. J. et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43, 817\u2013824 (1993).","journal-title":"Neurology"},{"key":"BFnrendo2015130_CR27","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.2337\/dc12-1964","volume":"36","author":"S Tesfaye","year":"2013","unstructured":"Tesfaye, S., Boulton, A. J. M. & Dickenson, A. H. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care 36, 2456\u20132465 (2013).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/dmrr.1226","volume":"27","author":"PJ Dyck","year":"2011","unstructured":"Dyck, P. J. et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab. Res. Rev. 27, 620 (2011).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnrendo2015130_CR29","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2337\/diacare.28.10.2378","volume":"28","author":"L Vileikyte","year":"2005","unstructured":"Vileikyte, L. et al. Foot ulcer risk is lower in South Asian and African-Caribbean compared to European diabetic patients in the UK. The North-West diabetes foot care study. Diabetes Care 28, 1869\u20131875 (2005).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/NRL.0b013e31815a3956","volume":"14","author":"AG Smith","year":"2008","unstructured":"Smith, A. G. & Singleton, J. R. Impaired glucose tolerance and neuropathy. Neurologist 14, 23\u201329 (2008).","journal-title":"Neurologist"},{"key":"BFnrendo2015130_CR31","first-page":"65","volume":"12","author":"S Tesfaye","year":"2011","unstructured":"Tesfaye, S. et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab. Res. Rev. 12, 65\u201368 (2011).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnrendo2015130_CR32","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1001\/jama.1977.03280220059023","volume":"238","author":"JL Davis","year":"1977","unstructured":"Davis, J. L. et al. Peripheral diabetic neuropathy treated with amitryptiline and fluphenazine. JAMA 238, 2291\u20132292 (1977).","journal-title":"JAMA"},{"key":"BFnrendo2015130_CR33","first-page":"1471","volume":"29","author":"A Sultan","year":"2008","unstructured":"Sultan, A., Gaskell, H., Derry, S. & Moore, R. A. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: a systematic review of randomised trials. BMC Neurol. 29, 1471\u20132377 (2008).","journal-title":"BMC Neurol."},{"key":"BFnrendo2015130_CR34","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","volume":"22","author":"A Caraceni","year":"2004","unstructured":"Caraceni, A. et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J. Clin. Oncol. 22, 2909\u20132917 (2004).","journal-title":"J. Clin. Oncol."},{"key":"BFnrendo2015130_CR35","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","volume":"280","author":"M Backonja","year":"1998","unstructured":"Backonja, M. et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280, 1831\u20131836 (1998).","journal-title":"JAMA"},{"key":"BFnrendo2015130_CR36","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/dc07-2105","volume":"31","author":"R Freeman","year":"2008","unstructured":"Freeman, R., Durso-Decruz, E. & Emir, B. Efficacy, safety and tolerability of pregabalin treatment for painful peripheral neuropathy: findings from seven randomised, controlled trials across a range of doses. Diabetes Care 31, 1448\u20131454 (2008).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR37","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/BF00401767","volume":"38","author":"SJ Morris","year":"1995","unstructured":"Morris, S. J., Shore, A. C. & Tooke, J. E. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with non-insulin dependent diabetes mellitus. Diabetologia 38, 1337\u20131344 (1995).","journal-title":"Diabetologia"},{"key":"BFnrendo2015130_CR38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1464-5491.1990.tb01477.x","volume":"7","author":"RE Ryder","year":"1990","unstructured":"Ryder, R. E. et al. Autonomic dennervation may be a prerequisite of diabetic neuropathic foot ulceration. Diabetic Med. 7, 726\u2013730 (1990).","journal-title":"Diabetic Med."},{"key":"BFnrendo2015130_CR39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00125-002-1004-5","volume":"246","author":"JD LeFrandt","year":"2003","unstructured":"LeFrandt, J. D. et al. Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathy. Diabetologia 246, 40\u201347 (2003).","journal-title":"Diabetologia"},{"issue":"Suppl.","key":"BFnrendo2015130_CR40","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren, L. et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 45 (Suppl.), S5\u2013S67 (2007).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR41","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1161\/CIRCULATIONAHA.107.736108","volume":"117","author":"MM McDermott","year":"2008","unstructured":"McDermott, M. M. et al. Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation 117, 2484\u20132491 (2008).","journal-title":"Circulation"},{"key":"BFnrendo2015130_CR42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ije\/20.2.384","volume":"20","author":"FG Fowkes","year":"1991","unstructured":"Fowkes F. G. et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 20, 384\u2013392 (1991).","journal-title":"Int. J. Epidemiol."},{"issue":"Suppl. 2","key":"BFnrendo2015130_CR43","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1078-5884(11)60009-9","volume":"42","author":"F Becker","year":"2011","unstructured":"Becker, F. et al. Chapter I: Definitions, epidemiology, clinical presentation and prognosis. Eur. J. Vasc. Endovasc. Surg. 42 (Suppl. 2), S4\u2013S12 (2011).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"BFnrendo2015130_CR44","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/dc05-2031","volume":"29","author":"EJ Boyko","year":"2006","unstructured":"Boyko, E. J., Ahroni, J. H., Cohen, V., Nelson, K. M. & Heagerty, P. J. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care 29, 1202\u20131207 (2006).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR45","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/ndt\/gfl427","volume":"21","author":"FL Game","year":"2006","unstructured":"Game, F. L., Chipchase, S. Y., Hubbard, R., Burden, R. P. & Jeffcoate, W. J. Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus. Nephrol. Dial. Transplant. 21, 3207\u20133210 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrendo2015130_CR46","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2337\/dc10-0255","volume":"33","author":"A Ndip","year":"2010","unstructured":"Ndip, A. et al. Dialysis treatment is an independent risk factor for foot ulceration in patients with diabetes and stage 4 or 5 chronic kidney disease. Diabetes Care 33, 1811\u20131816 (2010).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR47","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2337\/dc09-2007","volume":"33","author":"A Ndip","year":"2010","unstructured":"Ndip, A. et al. High levels of foot ulceration and amputation risk in a multiracial cohort of diabetic patients on dialysis therapy. Diabetes Care 33, 878\u2013880 (2010).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2337\/diacare.22.1.157","volume":"22","author":"GE Reiber","year":"1999","unstructured":"Reiber, G. E. et al. Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care 22, 157\u2013162 (1999).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR49","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2337\/dc08-9021","volume":"31","author":"AJM Boulton","year":"2008","unstructured":"Boulton, A. J. M. et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 31, 1679\u20131685 (2008).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/dc07-1178","volume":"31","author":"S Krishnan","year":"2008","unstructured":"Krishnan, S., Nash, F., Baker, N., Fowler, D. & Rayman, G. Reduction in diabetic amputations over eleven years in a defined UK population: benefits of multi-disciplinary team work and continuous prospective audit. Diabetes Care 31, 99\u2013101 (2008).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jama.2011.1900","volume":"308","author":"BM Kuehn","year":"2012","unstructured":"Kuehn, B. M. Prompt response, multi-disciplinary care: key to reducing diabetic foot amputation. JAMA 308, 19\u201320 (2012).","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"BFnrendo2015130_CR52","first-page":"S13","volume":"42","author":"P Cao","year":"2011","unstructured":"Cao, P. et al. Chapter II: Diagnostic methods. Eur. J. Vasc. Endovasc. Surg. 42 (Suppl. 2), S13\u2013S32 (2011).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"BFnrendo2015130_CR53","first-page":"67","volume":"25","author":"SA Carter","year":"2006","unstructured":"Carter, S. A. & Tate, R. B. The relationship of the transcutaneous oxygen tension, pulse waves and systolic pressures to the risk for limb amputation in patients with peripheral arterial disease and skin ulcers or gangrene. Int. Angiol. 25, 67\u201372 (2006).","journal-title":"Int. Angiol."},{"key":"BFnrendo2015130_CR54","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/bmj.39217.473275.55","volume":"334","author":"R Collins","year":"2007","unstructured":"Collins, R. et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ 334, 1257 (2007).","journal-title":"BMJ"},{"key":"BFnrendo2015130_CR55","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jama.301.4.415","volume":"301","author":"R Met","year":"2009","unstructured":"Met, R., Bipat, S., Legemate, D. A., Reekers, J. A. & Koelemay, M. J. W. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 301, 415\u2013424 (2009).","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"BFnrendo2015130_CR56","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S1078-5884(11)60011-7","volume":"42","author":"N Diehm","year":"2011","unstructured":"Diehm, N. et al. Chapter III: Management of cardiovascular risk factors and medical therapy. Eur. J. Vasc. Endovasc. Surg. 42 (Suppl. 2), S33\u2013S42 (2011).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"BFnrendo2015130_CR57","doi-asserted-by":"publisher","unstructured":"Ruffolo, A. A. J., Romano, M. & Ciapponi, A. Prostanoids for critical limb ischaemia. Cochrane Database of Systematic Reviews Issue 1. Art. No.: CD006544 http:\/\/dx.doi.org\/10.1002\/14651858.CD006544.pub2 .","DOI":"10.1002\/14651858.CD006544.pub2"},{"key":"BFnrendo2015130_CR58","first-page":"1477","volume":"120","author":"FE Brock","year":"1990","unstructured":"Brock, F. E. et al. Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative. Schweiz. Med. Wochenschr. 120, 1477\u20131482 (1990).","journal-title":"Schweiz. Med. Wochenschr."},{"key":"BFnrendo2015130_CR59","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0952-3278(93)90163-Q","volume":"49","author":"HO Altstaedt","year":"1993","unstructured":"Altstaedt, H. O. et al. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study. Prostaglandins Leukot. Essent. Fatty Acids 49, 573\u2013578 (1993).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"BFnrendo2015130_CR60","first-page":"164","volume":"35","author":"H Stiegler","year":"1992","unstructured":"Stiegler, H. et al. Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease [German]. Vasa. Suppl. 35, 164\u2013166 (1992).","journal-title":"Vasa. Suppl."},{"key":"BFnrendo2015130_CR61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/dmrr.2253","volume":"28","author":"K Bakker","year":"2011","unstructured":"Bakker, K. et al. Practical guidelines on the management and prevention of the diabetic foot. Diabetes Metab. Res. Rev. 28, 225\u2013231 (2011).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnrendo2015130_CR62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jvs.2006.03.026","volume":"44","author":"WA Marston","year":"2006","unstructured":"Marston, W. A. et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J. Vasc. Surg. 44, 108\u2013114 (2006).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1078-5884(96)80044-X","volume":"11","author":"M Lep\u00e4ntalo","year":"1996","unstructured":"Lep\u00e4ntalo, M. & M\u00e4tzke, S. Outcome of unreconstructed chronic critical leg ischaemia. Eur. J. Vasc. Endovasc. Surg. 11, 153\u2013157 (1996).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"BFnrendo2015130_CR64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jvs.2011.10.089","volume":"55","author":"E Benoit","year":"2012","unstructured":"Benoit, E., O'Donnell, T. F., Kitsios, G. D. & Iafrati, M. D. Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. J. Vasc. Surg. 55, 781\u2013789 (2012).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR65","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejvs.2006.03.006","volume":"32","author":"E Faglia","year":"2006","unstructured":"Faglia, E. et al. Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur. J. Vasc. Endovasc. Surg. 32, 484\u2013490 (2006).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"BFnrendo2015130_CR66","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jvs.2004.01.027","volume":"39","author":"ZK Baldwin","year":"2004","unstructured":"Baldwin, Z. K. et al. Limb salvage after infrainguinal bypass graft failure. J. Vasc. Surg. 39, 951\u2013957 (2004).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR67","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jvs.2006.12.022","volume":"45","author":"F Dick","year":"2007","unstructured":"Dick, F. et al. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J. Vasc. Surg. 45, 751\u2013761 (2007).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR68","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jvs.2009.08.043","volume":"51","author":"J Kalish","year":"2010","unstructured":"Kalish, J. & Hamdan, A. Management of diabetic foot problems. J. Vasc. Surg. 51, 476\u2013486 (2010).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR69","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jvs.2014.03.012","volume":"59","author":"R Wu","year":"2014","unstructured":"Wu, R. et al. Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arterial disease: a meta-analysis of randomized trials. J. Vasc. Surg. 59, 1711\u20131720 (2014).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR70","first-page":"99","volume":"7","author":"JA Bekken","year":"2014","unstructured":"Bekken, J. A., Jongsma, H., de Vries, J. P. & Fioole, B. Self-expanding stents and aortoiliac occlusive disease: a review of the literature. Med. Devices 7, 99\u2013105 (2014).","journal-title":"Med. Devices"},{"key":"BFnrendo2015130_CR71","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jvs.2005.11.025","volume":"43","author":"M Albers","year":"2006","unstructured":"Albers, M., Romiti, M., Brochado-Neto, F. C., De Luccia, N. & Pereira, C. A. B. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J. Vasc. Surg. 43, 498\u2013503 (2006).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR72","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jvs.2014.04.071","volume":"60","author":"GH Skrepnek","year":"2014","unstructured":"Skrepnek, G. H., Armstrong, D. G. & Mills, J. L. Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010. J. Vasc. Surg. 60, 1255\u20131264 (2014).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR73","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","volume":"366","author":"DJ Adam","year":"2005","unstructured":"Adam, D. J. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366, 1925\u20131934 (2005).","journal-title":"Lancet"},{"key":"BFnrendo2015130_CR74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejvs.2014.04.002","volume":"48","author":"DC Bosanquet","year":"2014","unstructured":"Bosanquet, D. C., Glasbey, J. C., Williams, I. M. & Twine, C. P. Systematic review and meta-analysis of direct versus indirect angiosomal revascularisation of infrapopliteal arteries. Eur. J. Vasc. Endovasc. Surg. 48, 88\u201397 (2014).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"BFnrendo2015130_CR75","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jvs.2011.08.014","volume":"55","author":"O Iida","year":"2012","unstructured":"Iida, O. et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J. Vasc. Surg. 55, 363\u2013370 (2012).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jvs.2012.07.057","volume":"57","author":"M S\u00f6derstr\u00f6m","year":"2013","unstructured":"S\u00f6derstr\u00f6m, M. et al. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J. Vasc. Surg. 57, 427\u2013435 (2013).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR77","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jvs.2013.06.056","volume":"58","author":"BE Sumpio","year":"2013","unstructured":"Sumpio, B. E. et al. Clinical implications of the angiosome model in peripheral vascular disease. J. Vasc. Surg. 58, 814\u2013826 (2013).","journal-title":"J. Vasc. Surg."},{"key":"BFnrendo2015130_CR78","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.semvascsurg.2012.04.001","volume":"25","author":"RF Neville","year":"2012","unstructured":"Neville, R. F. & Sidawy, A. N. Surgical bypass: when is it best and do angiosomes play a role? Semin. Vasc. Surg. 25, 102\u2013107 (2012).","journal-title":"Semin. Vasc. Surg."},{"issue":"Suppl. 1","key":"BFnrendo2015130_CR79","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/dmrr.2249","volume":"28","author":"R Hinchliffe","year":"2012","unstructured":"Hinchliffe, R. & Andros, G. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab. Res. Rev. 28 (Suppl. 1), 179\u2013217 (2012).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnrendo2015130_CR80","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejvs.2008.01.027","volume":"36","author":"M S\u00f6derstr\u00f6m","year":"2008","unstructured":"S\u00f6derstr\u00f6m, M., Arvela, E., Alb\u00e4ck, A., Aho, P. S. & Lep\u00e4ntalo, M. Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia. Eur. J. Vasc. Endovasc. Surg. 36, 90\u201395 (2008).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"BFnrendo2015130_CR81","unstructured":"University of Birmingham BASIL-2 Trial [online] , (2015)."},{"key":"BFnrendo2015130_CR82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1067-2516(99)80066-0","volume":"38","author":"DL Pitei","year":"1999","unstructured":"Pitei, D. L., Foster, A. & Edmonds, M. The effect of regular callus removal on foot pressures. J. Foot Ankle Surg. 38, 251\u2013255 (1999).","journal-title":"J. Foot Ankle Surg."},{"key":"BFnrendo2015130_CR83","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2337\/diacare.28.3.551","volume":"28","author":"DG Armstrong","year":"2005","unstructured":"Armstrong, D. G. et al. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomised controlled trial. Diabetes Care 28, 551\u2013554 (2005).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR84","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/dc10-2206","volume":"34","author":"SA Bus","year":"2011","unstructured":"Bus, S. A., Haspels, R. & Busch-Westbroek, T. E. Evaluation and optimisation of therapeutic footwear for neuropathic diabetic foot patients using in-shoe plantar pressure analysis. Diabetes Care 34, 1595\u20131600 (2011).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR85","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2337\/diacare.28.3.555","volume":"28","author":"IA Katz","year":"2005","unstructured":"Katz, I. A. et al. A randomised controlled trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 28, 555\u2013559 (2005).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR86","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/diacare.26.9.2595","volume":"26","author":"DG Armstrong","year":"2003","unstructured":"Armstrong, D. G. et al. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to standard pressure off-loading regimen. Diabetes Care 26, 2595\u20132597 (2003).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR87","doi-asserted-by":"publisher","unstructured":"Dumville, J. C., Deschpande, S., O'Meara, S. & Speak, K. Hydrocolloid dressings for healing diabetic foot ulcers. Cochrane Database of Systematic Reviews Issue 8. Art. No.: CD009099 http:\/\/dx.doi.org\/10.1002\/14651858.CD009099.pub3 .","DOI":"10.1002\/14651858.CD009099.pub3"},{"key":"BFnrendo2015130_CR88","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1464-5491.2007.02079.x","volume":"24","author":"EB Jude","year":"2007","unstructured":"Jude, E. B., Apelqvist, J., Spraul, M. & Martini, J. Silver dressing study group. Prospective randomised controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressing in non-ischameic diabetic foot ulcers. Diabetic Med. 24, 280\u2013288 (2007).","journal-title":"Diabetic Med."},{"key":"BFnrendo2015130_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13540","volume":"13","author":"WJ Jeffcoate","year":"2009","unstructured":"Jeffcoate, W. J. et al. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technol. Assess. 13, 1\u201386 (2009).","journal-title":"Health Technol. Assess."},{"key":"BFnrendo2015130_CR90","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.PRS.0000135330.51408.97","volume":"114","author":"V Saxena","year":"2004","unstructured":"Saxena, V. et al. Vacuum assisted closure: microdeformations of wound and cell proliferation. Plast. Reconstr. Surg. 114, 1086\u20131098 (2004).","journal-title":"Plast. Reconstr. Surg."},{"key":"BFnrendo2015130_CR91","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/S0140-6736(05)67695-7","volume":"366","author":"DG Armstrong","year":"2005","unstructured":"Armstrong, D. G. & Lavery, L. A. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 366, 1704\u20131710 (2005).","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"BFnrendo2015130_CR92","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0020-1383(11)00041-6","volume":"42","author":"E Krug","year":"2011","unstructured":"Krug, E. et al. Evidence-based recommendations for the use of negative pressure wound therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus. Injury 42 (Suppl. 1), S1\u2013S12 (2011).","journal-title":"Injury"},{"key":"BFnrendo2015130_CR93","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.2003.83.3.835","volume":"83","author":"S Werner","year":"2003","unstructured":"Werner, S. & Grose, R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83, 835\u2013870 (2003).","journal-title":"Physiol. Rev."},{"key":"BFnrendo2015130_CR94","doi-asserted-by":"publisher","unstructured":"Henshaw, F. R., Boughton, P., Lo, L., McLennan, S. V. & Twigg, S. M. Topically applied connective tissue growth factor\/CCN2 improves diabetic preclinical cutaneous wound healing: potential role for CTGF in human diabetic foot ulcer healing. J. Diabetes Res. http:\/\/dx.doi.org\/10.1155\/2015\/236238 .","DOI":"10.1155\/2015\/236238"},{"key":"BFnrendo2015130_CR95","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/CIA.S1106","volume":"3","author":"N Pappanas","year":"2008","unstructured":"Pappanas, N. & Maltosze, E. Becaplermin is form recombinant platelet-derived growth factor available as an ointment and has shown some benefit. Clin.Interv.Aging 3, 233\u2013240 (2008).","journal-title":"Clin.Interv.Aging"},{"key":"BFnrendo2015130_CR96","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/sj.leu.2400811","volume":"11","author":"MC Dignani","year":"1997","unstructured":"Dignani, M. C. et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 11, 1621\u20131630 (1997).","journal-title":"Leukemia"},{"key":"BFnrendo2015130_CR97","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2337\/diacare.28.2.454","volume":"28","author":"M Cruciani","year":"2005","unstructured":"Cruciani, M., Lipsky, B. A., Mengoli, C. & de Lalla, F. Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections? A meta-analysis. Diabetes Care 28, 454\u2013460 (2005).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR98","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/ten.tea.2011.0738","volume":"19","author":"JS Choi","year":"2013","unstructured":"Choi, J. S., Kim, J. D., Yoon, H. S. & Cho, Y. W. Full-thickness skin wound healing using human placenta-derived extracellular matrix containing bioactive molecules. Tissue Eng. Part A 19, 329\u2013339 (2013).","journal-title":"Tissue Eng. Part A"},{"key":"BFnrendo2015130_CR99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7812\/TPP\/10-124","volume":"15","author":"C Antoline","year":"2011","unstructured":"Antoline, C., Kramer, A. & Roth, M. Implementation and methodology of a multidisciplinary disease-state-management program for comprehensive diabetes care. Permanenta J. 15, 43\u201348 (2011).","journal-title":"Permanenta J."},{"key":"BFnrendo2015130_CR100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/dc07-1178","volume":"31","author":"S Krishnan","year":"2008","unstructured":"Krishnan, S., Nash, F., Baker, N., Fowler, D. & Rayman, G. Reduction in diabetic amputations over eleven years in a defined UK population: benefits of multi-disciplinary team work and continuous prospective audit. Diabetes Care 31, 99\u2013101 (2008).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR101","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2337\/dc11-0156","volume":"34","author":"G Rayman","year":"2011","unstructured":"Rayman, G. et al. The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care 34, 1517\u20131518 (2011).","journal-title":"Diabetes Care"},{"key":"BFnrendo2015130_CR102","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1464-5491.2012.03730.x","volume":"29","author":"FL Bowling","year":"2012","unstructured":"Bowling, F. L. et al. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting. Diabetic Med. 29, 1550\u20131552 (2012).","journal-title":"Diabetic Med."},{"key":"BFnrendo2015130_CR103","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/dme.12000","volume":"30","author":"N Papanas","year":"2013","unstructured":"Papanas, N. et al. Neuropad: A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabetic Med. 30, 525\u2013534 (2013).","journal-title":"Diabetic Med."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.130","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2015.130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T03:00:23Z","timestamp":1691895623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2015.130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,18]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFnrendo2015130"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2015.130","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,18]]},"assertion":[{"value":"18 August 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}